These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32298194)

  • 1. Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccine.
    Alcorn JF; Avula R; Chakka AB; Schwarzmann WE; Nowalk MP; Lin CJ; Ortiz MA; Horne WT; Chandran UR; Nagg JP; Zimmerman RK; Cole KS; Moehling KK; Martin JM
    Hum Vaccin Immunother; 2020 Aug; 16(8):1782-1790. PubMed ID: 32298194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Induction of Interferon-Stimulated Genes by Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Children During the 2018-2019 Season.
    Martin JM; Moehling Geffel K; Ortiz MA; Rajasundaram D; Nowalk MP; Zimmerman RK; Alcorn JF
    J Infect Dis; 2024 May; 229(5):1393-1401. PubMed ID: 37665976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential gene expression elicited by children in response to the 2015-16 live attenuated versus inactivated influenza vaccine.
    Cole KS; Martin JM; Horne WT; Lin CJ; Nowalk MP; Alcorn JF; Zimmerman RK
    Vaccine; 2017 Dec; 35(49 Pt B):6893-6897. PubMed ID: 29132989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination features revealed by a single-cell transcriptome atlas.
    Wang Y; Wang X; Jia X; Li J; Fu J; Huang X; Cui X; Wang B; Luo W; Lin C; Li Z; Luu LDW; Li S; Zhu X; Tai J
    J Med Virol; 2023 Jan; 95(1):e28174. PubMed ID: 36163452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-specific differences of humoral immunity and transcriptome diversification in older adults vaccinated with inactivated quadrivalent influenza vaccines.
    Yang J; Huang X; Zhang J; Fan R; Zhao W; Han T; Duan K; Li X; Zeng P; Deng J; Zhang J; Yang X
    Aging (Albany NY); 2021 Mar; 13(7):9801-9819. PubMed ID: 33744852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.
    Mbawuike IN; Atmar RL; Patel SM; Corry DB; Winokur PL; Brady RC; Chen WH; Edwards KM; Creech CB; Walter EB; Frey SE; Belshe RB; Goll JB; Hill H; Keitel WA
    Vaccine; 2016 Jan; 34(4):547-554. PubMed ID: 26657997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immune responses elicited by an intranasal inactivated H5 influenza vaccine.
    Ainai A; van Riet E; Ito R; Ikeda K; Senchi K; Suzuki T; Tamura SI; Asanuma H; Odagiri T; Tashiro M; Kurata T; Multihartina P; Setiawaty V; Pangesti KNA; Hasegawa H
    Microbiol Immunol; 2020 Apr; 64(4):313-325. PubMed ID: 31957054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-dependent cell-mediated cytotoxicity antibody responses to inactivated and live-attenuated influenza vaccination in children during 2014-15.
    Florek K; Mutschler J; McLean HQ; King JP; Flannery B; Belongia EA; Friedrich TC
    Vaccine; 2020 Feb; 38(8):2088-2094. PubMed ID: 31753674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza Vaccine-Induced Antibody Responses Are Not Impaired by Frailty in the Community-Dwelling Elderly With Natural Influenza Exposure.
    Narang V; Lu Y; Tan C; Camous XFN; Nyunt SZ; Carre C; Mok EWH; Wong G; Maurer-Stroh S; Abel B; Burdin N; Poidinger M; Tambyah PA; Bosco N; Visan L; Ng TP; Larbi A
    Front Immunol; 2018; 9():2465. PubMed ID: 30405641
    [No Abstract]   [Full Text] [Related]  

  • 11. A Randomized, Double-blind, Active-controlled Phase III Trial of a Cell Culture-derived Quadrivalent Inactivated Influenza Vaccine in Healthy South Korean Children and Adolescents 6 Months to 18 Years of Age.
    Eun BW; Lee TJ; Lee J; Kim KH; Kim DH; Jo DS; Shin SH; Kim H; Kim KH; Kim YK
    Pediatr Infect Dis J; 2019 Sep; 38(9):e209-e215. PubMed ID: 31335572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A shortened interval between vaccinations with the trivalent inactivated influenza vaccine increases responsiveness in the aged.
    Kannan S; Kossenkov A; Kurupati RK; Xiang JZ; Doyle SA; Schmader KE; Schowe L; Ertl HC
    Aging (Albany NY); 2015 Dec; 7(12):1077-85. PubMed ID: 26637961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.
    He XS; Holmes TH; Zhang C; Mahmood K; Kemble GW; Lewis DB; Dekker CL; Greenberg HB; Arvin AM
    J Virol; 2006 Dec; 80(23):11756-66. PubMed ID: 16971435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.
    Wang W; Chen Q; Ford-Siltz LA; Katzelnick LC; Parra GI; Song HS; Vassell R; Weiss CD
    Clin Infect Dis; 2019 May; 68(12):2067-2078. PubMed ID: 30256912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial predictors of the innate immune response to influenza vaccination.
    Kuhlman KR; Radin A; Cole SW; Bower JE
    Psychoneuroendocrinology; 2024 May; 163():106989. PubMed ID: 38354453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6-35 Months.
    Lee JH; Cho HK; Kim KH; Lee J; Kim YJ; Eun BW; Kim NH; Kim DH; Jo DS; Kim HM; Kim YK
    J Korean Med Sci; 2019 Dec; 34(46):e279. PubMed ID: 31779056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59 months of age: A phase 3, randomized, noninferiority study.
    Statler VA; Albano FR; Airey J; Sawlwin DC; Graves Jones A; Matassa V; Heijnen E; Edelman J; Marshall GS
    Vaccine; 2019 Jan; 37(2):343-351. PubMed ID: 30057283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial.
    Vesikari T; Kirstein J; Devota Go G; Leav B; Ruzycky ME; Isakov L; de Bruijn M; Oberye J; Heijnen E
    Lancet Respir Med; 2018 May; 6(5):345-356. PubMed ID: 29631857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation.
    Quach HQ; Goergen KM; Grill DE; Haralambieva IH; Ovsyannikova IG; Poland GA; Kennedy RB
    Front Immunol; 2023; 14():1168784. PubMed ID: 37600811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.